電信業者篩檢的市場佔有率,規模,趨勢,產業分析:各類型(擴張電信業者篩檢,標的疾病電信業者篩檢),各病情,各技術,各終端用戶,各地區,市場區隔預測(2022年~2030年)
市場調查報告書
商品編碼
1078372

電信業者篩檢的市場佔有率,規模,趨勢,產業分析:各類型(擴張電信業者篩檢,標的疾病電信業者篩檢),各病情,各技術,各終端用戶,各地區,市場區隔預測(2022年~2030年)

Carrier Screening Market Share, Size, Trends, Industry Analysis Report, By Type (Expanded Carrier Screening, Targeted Disease Carrier Screening); By Medical Condition; By Technology; By End-User; By Regions; Segment Forecast, 2022 - 2030

出版日期: | 出版商: Polaris Market Research | 英文 114 Pages | 商品交期: 最快1-2個工作天內

價格

全球電信業者篩檢的市場規模,至2030年達到36億4,000萬美元。

本報告提供全球電信業者篩檢市場調查,市場概要,市場的推動因素與阻礙因素的分析,市場機會,COVID-19的影響,各類型、各病情、各技術、各終端用戶、各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 報告的說明
    • 調查的目的
    • 市場範圍
    • 前提條件
  • 利害關係者

第2章 摘要整理

  • 市場概況

第3章 調查手法

  • 概要
    • 資料探勘
  • 資料來源
    • 第一手資料
    • 第二手資料

第4章 全球電信業者篩檢市場洞察

  • 產業概述
  • 市場動態
    • 促進因素和機會
    • 阻礙因素與課題
  • 波特的五力分析
    • 供給企業談判力(中)
    • 新加入廠商的威脅(低)
    • 買方議價能力(中)
    • 替代威脅(中)
    • 現有企業間的競爭(高)
  • 大環境分析
  • 產業趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球電信業者篩檢市場:各病情

  • 主要調查結果
  • 簡介
    • 各病情(2018年~2030年)
  • 肺部疾病
    • 各肺部疾病,各地區(2018年~2030年)
  • 血液疾病
    • 各血液疾病,各地區(2018年~2030年)
  • 神經疾病
    • 各神經疾病,各地區(2018年~2030年)
  • 其他疾病
    • 其他疾病,各地區(2018年~2030年)

第6章 全球電信業者篩檢市場:各類型

  • 主要調查結果
  • 簡介
    • 各類型(2018年~2030年)
  • 擴張
    • 各擴張,各地區(2018年~2030年)
    • 客製化型面板試驗
    • 事前設計型面板試驗
  • 標的疾病
    • 各標的疾病,各地區(2018年~2030年)

第7章 全球電信業者篩檢市場:各技術

  • 主要調查結果
  • 簡介
    • 各技術(2018年~2030年)
  • DNA定序
    • 各DNA定序,各地區(2018年~2030年)
  • 聚合酵素鏈鎖反應
    • 各聚合酵素鏈鎖反應,各地區(2018年~2030年)
  • 微陣列
    • 各微陣列,各地區(2018年~2030年)
  • 其他技術
    • 各其他技術,各地區(2018年~2030年)

第8章 全球電信業者篩檢市場:各終端用戶

  • 主要調查結果
  • 簡介
    • 各終端用戶(2018年~2030年)
  • 醫院
    • 各醫院,各地區(2018年~2030年)
  • 參考實驗室
    • 各參考實驗室,各地區(2018年~2030年)
  • 診療所、診所
    • 各診療所、診所,各地區(2018年~2030年)
  • 其他的終端用戶
    • 其他的各終端用戶,各地區(2018年~2030年)

第9章 全球電信業者篩檢市場:各地區

  • 主要調查結果
  • 簡介
    • 市場評估:各地區(2018年~2030年)
  • 北美
    • 各病情(2018年~2030年)
    • 各終端用戶(2018年~2030年)
    • 各類型(2018年~2030年)
    • 各技術(2018年~2030年)
    • 美國
    • 加拿大
  • 歐洲
    • 各病情(2018年~2030年)
    • 各終端用戶(2018年~2030年)
    • 各類型(2018年~2030年)
    • 各技術(2018年~2030年)
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 奧地利
  • 亞太地區
    • 各病情(2018年~2030年)
    • 各終端用戶(2018年~2030年)
    • 各類型(2018年~2030年)
    • 各技術(2018年~2030年)
    • 中國
    • 印度
    • 日本
    • 馬來西亞
    • 印尼
    • 韓國
  • 中東、非洲
    • 各病情(2018年~2030年)
    • 各終端用戶(2018年~2030年)
    • 各類型(2018年~2030年)
    • 各技術(2018年~2030年)
    • 沙烏地阿拉伯
    • 南非
    • 以色列
    • 阿拉伯聯合大公國
  • 南美
    • 各病情(2018年~2030年)
    • 各終端用戶(2018年~2030年)
    • 各類型(2018年~2030年)
    • 各技術(2018年~2030年)
    • 墨西哥
    • 巴西
    • 阿根廷

第10章 競爭情形

  • 事業擴張、企業收購的分析
    • 事業擴張
    • 企業收購
  • 夥伴關係/合作/契約/展示會

第11章 企業簡介

  • 23Andme Inc.
  • Abbott Laboratories
  • Autogenomics Inc.
  • Danaher Corporation
  • Eurofins Scientific
  • Fulgent Genetics Inc.
  • Illumina Inc.
  • Invitae Corporation
  • Luminex Corporation
  • MedGenome
  • Myriad Genetics
  • Natera Inc.
  • Opko Health
  • Quest Diagnostics Incorporated
  • Roche AG
  • Sequenom Inc.
  • Thermo Fisher Scientific Inc.
  • True Health
Product Code: PM2300

The global carrier screening market size is expected to reach USD 3.64 billion by 2030, according to a new study by Polaris Market Research. The report "Carrier Screening Market Share, Size, Trends, Industry Analysis Report, By Type (Expanded Carrier Screening, Targeted Disease Carrier Screening); By Medical Condition; By Technology; By End-User; By Regions; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The well-established healthcare infrastructure and the rise in innovative product introductions are driving the expansion of the industry. Many countries concentrate their efforts on developing enhanced medical infrastructure that includes enhanced treatment techniques.

Furthermore, developed-country nations have modern healthcare infrastructure integrated with various transmission methods, pushing the rise and need for these techniques throughout such countries. Many people wish to discover if their genetic or inherited disorders might be transmitted to their offerings. As a result, these factors are expected to open up promising growth opportunities for companies in the overall industry during the forecasted period.

Additionally, the increasing prevalence of fetal chromosomal abnormalities boosts industry growth. According to the WHO, congenital abnormalities are major causes of fetal and infant mortality, chronic illness, and disabilities. Every year, an estimated 295 000 newborns nationwide die within 28 days of birth due to congenital abnormalities. Thus, the rising prevalence of fetal abnormalities, increasing product launches, and established healthcare infrastructure propel the industry growth during the forecast period.

Based on the type, the expanded segment accounted for the leading share in the industry in 2021. Customized panel testing and predesigned panel testing are the extended segment components. Due to advancements in DNA sequencing, polymerase chain reaction, metabolomics, and other technologies, the expanded sector accounted for most of the global market share in 2021.

Market players such as Abbott Laboratories, 23Andme Inc., Autogenomics Inc., Danaher Corporation, Fulgent Genetics Inc., Eurofins Scientific, Illumina Inc., Luminex Corporation, Invitae Corporation, MedGenome, Natera Inc., Myriad Genetics, Opko Health, Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc., Roche AG, Sequenom Inc., and True Health. are some key players operating in the global market.

Polaris Market Research has segmented the carrier screening market report based on type, medical condition, technology, end-user, and region:

Carrier Screening, Type Outlook (Revenue - USD Billion, 2018 - 2030)

Expanded

Customized Panel Testing

Predesigned Panel Testing

Targeted Disease

Carrier Screening, Medical Condition Outlook (Revenue - USD Billion, 2018 - 2030)

Pulmonary Conditions

Hematological Conditions

Neurological Conditions

Other Conditions

Carrier Screening, Technology Outlook (Revenue - USD Billion, 2018 - 2030)

DNA Sequencing

Polymerase Chain Reaction

Microarrays

Other Technologies

Carrier Screening, End-User Outlook (Revenue - USD Billion, 2018 - 2030)

Hospitals

Reference Laboratories

Physician Offices & Clinics

Other End Users

Carrier Screening, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S.

Canada

Europe

France

Germany

UK

Italy

Netherlands

Spain

Austria

Asia Pacific

China

India

Japan

Malaysia

South Korea

Indonesia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Carrier Screening Market Insights

  • 4.1. Carrier Screening - Industry Snapshot
  • 4.2. Carrier Screening Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing emphasis on early disease detection & prevention
      • 4.2.1.2. Increasing awareness of carrier screening
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of service
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Carrier Screening Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Carrier Screening Market, by Medical Condition

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • 5.3. Pulmonary Conditions
    • 5.3.1. Global Carrier Screening Market, by Pulmonary Conditions, by Region, 2018 - 2030 (USD Billion)
  • 5.4. Hematological Conditions
    • 5.4.1. Global Carrier Screening Market, by Hematological Conditions, by Region, 2018 - 2030 (USD Billion)
  • 5.5. Neurological Conditions
    • 5.5.1. Global Carrier Screening Market, by Neurological Conditions, by Region, 2018 - 2030 (USD Billion)
  • 5.6. Other Conditions
    • 5.6.1. Global Carrier Screening Market, by Other Conditions, by Region, 2018 - 2030 (USD Billion)

6. Global Carrier Screening Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • 6.3. Expanded
    • 6.3.1. Global Carrier Screening Market, by Expanded, by Region, 2018 - 2030 (USD Billion)
    • 6.3.2. Customized Panel Testing
      • 6.3.2.1. Global Carrier Screening Market, by Customized Panel Testing, by Region, 2018 - 2030 (USD Billion)
    • 6.3.3. Predesigned Panel Testing
      • 6.3.3.1. Global Carrier Screening Market, by Predesigned Panel Testing, by Region, 2018 - 2030 (USD Billion)
  • 6.4. Targeted Disease
    • 6.4.1. Global Carrier Screening Market, by Targeted Disease, by Region, 2018 - 2030 (USD Billion)

7. Global Carrier Screening Market, by Technology

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • 7.3. DNA Sequencing
    • 7.3.1. Global Carrier Screening Market, by DNA Sequencing, by Region, 2018 - 2030 (USD Billion)
  • 7.4. Polymerase Chain Reaction
    • 7.4.1. Global Carrier Screening Market, by Polymerase Chain Reaction, by Region, 2018 - 2030 (USD Billion)
  • 7.5. Microarrays
    • 7.5.1. Global Carrier Screening Market, by Microarrays, by Region, 2018 - 2030 (USD Billion)
  • 7.6. Other Technologies
    • 7.6.1. Global Carrier Screening Market, by Other Technologies, by Region, 2018 - 2030 (USD Billion)

8. Global Carrier Screening Market, by End-User

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • 8.3. Hospitals
    • 8.3.1. Global Carrier Screening Market, by Hospitals, by Region, 2018 - 2030 (USD Billion)
  • 8.4. Reference Laboratories
    • 8.4.1. Global Carrier Screening Market, by Reference Laboratories, by Region, 2018 - 2030 (USD Billion)
  • 8.5. Physician Offices & Clinics
    • 8.5.1. Global Carrier Screening Market, by Physician Offices & Clinics, by Region, 2018 - 2030 (USD Billion)
  • 8.6. Other End Users
    • 8.6.1. Global Carrier Screening Market, by Other End Users, by Region, 2018 - 2030 (USD Billion)

9. Global Carrier Screening Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Carrier Screening Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • 9.3. Carrier Screening Market - North America
    • 9.3.1. North America: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
    • 9.3.2. North America: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
    • 9.3.3. North America: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
    • 9.3.4. North America: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.3.5. Carrier Screening Market - U.S.
      • 9.3.5.1. U.S.: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.3.5.2. U.S.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.3.5.3. U.S.: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.3.5.4. U.S.: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.3.6. Carrier Screening Market - Canada
      • 9.3.6.1. Canada: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.3.6.2. Canada: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.3.6.3. Canada: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.3.6.4. Canada: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.4. Carrier Screening Market - Europe
    • 9.4.1. Europe: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
    • 9.4.2. Europe: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
    • 9.4.3. Europe: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
    • 9.4.4. Europe: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.4.5. Carrier Screening Market - UK
      • 9.4.5.1. UK: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.4.5.2. UK: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.5.3. UK: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.4.5.4. UK: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.4.6. Carrier Screening Market - France
      • 9.4.6.1. France: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.4.6.2. France: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.6.3. France: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.4.6.4. France: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.4.7. Carrier Screening Market - Germany
      • 9.4.7.1. Germany: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.4.7.2. Germany: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.7.3. Germany: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.4.7.4. Germany: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.4.8. Carrier Screening Market - Italy
      • 9.4.8.1. Italy: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.4.8.2. Italy: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.8.3. Italy: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.4.8.4. Italy: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.4.9. Carrier Screening Market - Spain
      • 9.4.9.1. Spain: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.4.9.2. Spain: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.9.3. Spain: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.4.9.4. Spain: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.4.10. Carrier Screening Market - Netherlands
      • 9.4.10.1. Netherlands: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.4.10.2. Netherlands: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.10.3. Netherlands: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.4.10.4. Netherlands: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.4.11. Carrier Screening Market - Austria
      • 9.4.11.1. Austria: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.4.11.2. Austria.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.11.3. Austria: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.4.11.4. Austria: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.5. Carrier Screening Market - Asia Pacific
    • 9.5.1. Asia Pacific: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
    • 9.5.2. Asia Pacific: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
    • 9.5.3. Asia Pacific: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
    • 9.5.4. Asia Pacific: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.5.5. Carrier Screening Market - China
      • 9.5.5.1. China: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.5.5.2. China.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.5.5.3. China: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.5.5.4. China: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.5.6. Carrier Screening Market - India
      • 9.5.6.1. India: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.5.6.2. India.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.5.6.3. India: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.5.6.4. India: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.5.7. Carrier Screening Market - Japan
      • 9.5.7.1. Japan: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.5.7.2. Japan.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.5.7.3. Japan: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.5.7.4. Japan: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.5.8. Carrier Screening Market - Malaysia
      • 9.5.8.1. Malaysia: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.5.8.2. Malaysia.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.5.8.3. Malaysia: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.5.8.4. Malaysia: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.5.9. Carrier Screening Market - Indonesia
      • 9.5.9.1. Indonesia: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.5.9.2. Indonesia.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.5.9.3. Indonesia: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.5.9.4. Indonesia: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.5.10. Carrier Screening Market - South Korea
      • 9.5.10.1. South Korea: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.5.10.2. South Korea.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.5.10.3. South Korea: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.5.10.4. South Korea: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.6. Carrier Screening Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
    • 9.6.2. Middle East & Africa: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
    • 9.6.3. Middle East & Africa: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
    • 9.6.4. Middle East & Africa: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.6.5. Carrier Screening Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.6.6. Carrier Screening Market - South Africa
      • 9.6.6.1. South Africa: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.6.6.2. South Africa: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.6.6.3. South Africa: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.6.6.4. South Africa: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.6.7. Carrier Screening Market - Israel
      • 9.6.7.1. Israel: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.6.7.2. Israel: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.6.7.3. Israel: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.6.7.4. Israel: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.6.8. Carrier Screening Market - UAE
      • 9.6.8.1. UAE: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.6.8.2. UAE: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.6.8.3. UAE: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.6.8.4. UAE: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.7. Carrier Screening Market - Latin America
    • 9.7.1. Latin America: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
    • 9.7.2. Latin America: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
    • 9.7.3. Latin America: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
    • 9.7.4. Latin America: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.7.5. Carrier Screening Market - Mexico
      • 9.7.5.1. Mexico: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.7.5.2. Mexico: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.7.5.3. Mexico: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.7.5.4. Mexico: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.7.6. Carrier Screening Market - Brazil
      • 9.7.6.1. Brazil: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.7.6.2. Brazil: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.7.6.3. Brazil: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.7.6.4. Brazil: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.7.7. Carrier Screening Market - Argentina
      • 9.7.7.1. Argentina: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.7.7.2. Argentina: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.7.7.3. Argentina: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.7.7.4. Argentina: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. 23Andme Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Abbott Laboratories
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Autogenomics Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Danaher Corporation
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Eurofins Scientific
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Fulgent Genetics Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Illumina Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Invitae Corporation
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Luminex Corporation
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. MedGenome
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Myriad Genetics
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Natera Inc.
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Opko Health
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Quest Diagnostics Incorporated
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Roche AG
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development
  • 11.16. Sequenom Inc.
    • 11.16.1. Company Overview
    • 11.16.2. Financial Performance
    • 11.16.3. Product Benchmarking
    • 11.16.4. Recent Development
  • 11.17. Thermo Fisher Scientific Inc.
    • 11.17.1. Company Overview
    • 11.17.2. Financial Performance
    • 11.17.3. Product Benchmarking
    • 11.17.4. Recent Development
  • 11.18. True Health
    • 11.18.1. Company Overview
    • 11.18.2. Financial Performance
    • 11.18.3. Product Benchmarking
    • 11.18.4. Recent Development

List of Tables

  • Table 1 Global Carrier Screening Market, by Medical Condition, by Region, 2018 - 2030 (USD Billion)
  • Table 2 Global Carrier Screening Market, by Type, by Region, 2018 - 2030 (USD Billion)
  • Table 3 Global Carrier Screening Market, by Technology, by Region, 2018 - 2030 (USD Billion)
  • Table 4 Global Carrier Screening Market, by End-User, by Region, 2018 - 2030 (USD Billion)
  • Table 5 Carrier Screening Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • Table 6 North America: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 7 North America: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 8 North America: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 9 North America: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 10 U.S.: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 11 U.S.: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 12 U.S.: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 13 U.S.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 14 Canada: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 15 Canada: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 16 Canada: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 17 Canada: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 18 Europe: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 19 Europe: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 20 Europe: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 21 Europe: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 22 Germany: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 23 Germany: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 24 Germany: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 25 Germany: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 26 France: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 27 France: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 28 France: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 29 France: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 30 UK: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 31 UK: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 32 UK: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 33 UK: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 34 Italy: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 35 Italy: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 36 Italy: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 37 Italy: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 38 Netherlands: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 39 Netherlands: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 40 Netherlands: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 41 Netherlands: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 42 Spain: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 43 Spain: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 44 Spain: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 45 Spain: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 46 Austria: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 47 Austria: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 48 Austria: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 49 Austria: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 50 Asia Pacific: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 51 Asia Pacific: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 52 Asia Pacific: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 53 Asia Pacific: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 54 China: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 55 China: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 56 China: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 57 China: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 58 Japan: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 59 Japan: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 60 Japan: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 61 Japan: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 62 India: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 63 India: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 64 India: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 65 India: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 66 Indonesia: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 67 Indonesia: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 68 Indonesia: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 69 Indonesia: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 70 Malaysia: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 71 Malaysia: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 72 Malaysia: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 73 Malaysia: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 74 South Korea: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 75 South Korea: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 76 South Korea: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 77 South Korea: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 78 Latin America: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 79 Latin America: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 80 Latin America: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 81 Latin America: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 82 Brazil: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 83 Brazil: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 84 Brazil: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 85 Brazil: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 86 Mexico: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 87 Mexico: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 88 Mexico: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 89 Mexico: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 90 Argentina: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 91 Argentina: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 92 Argentina: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 93 Argentina: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 94 Middle East & Africa: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 95 Middle East & Africa: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 96 Middle East & Africa: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 97 Middle East & Africa: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 98 UAE: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 99 UAE: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 100 UAE: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 101 UAE: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 102 Saudi Arabia: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 103 Saudi Arabia: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 104 Saudi Arabia: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 105 Saudi Arabia: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 106 South Africa: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 107 South Africa: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 108 South Africa: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 109 South Africa: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 110 Israel: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 111 Israel: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 112 Israel: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 113 Israel: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)

List of Figures

  • Figure 1. Global Carrier Screening Market, 2018 - 2030 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up End-User
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Medical Condition
  • Figure 7. Global Carrier Screening Market, by Medical Condition, 2021 & 2030 (USD Billion)
  • Figure 8. Market by End-User
  • Figure 9. Global Carrier Screening Market, by End-User, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Type
  • Figure 11. Global Carrier Screening Market, by Type, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Technology
  • Figure 13. Global Carrier Screening Market, by Technology, 2021 & 2030 (USD Billion)
  • Figure 14. Carrier Screening Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • Figure 15. Strategic Analysis - Carrier Screening Market